1. Device for inspecting fast repetitive events of defined duration, comprising image recording means for recording successive images of the repetitive event, and image reproduction means for providing a synchronised slow motion representation of said successive images of the repetitive event during the total duration of the repetitive event or a multiple thereof, characterised in that said image recording means comprise high frame rate image recording means for digitally recording a limited burst of successive images of a fraction of one event, and the device comprises software means to provide synchronised image recording of said fraction of one event and slow motion representation of said limited burst of successive images during the total duration of said one event or multiple thereof.
2. Inspection device according to claim 1, characterised in that said software means involve an adjustable triggering signal for the coordinated image recording and slow motion representation.
3. Inspection device according to claim 2, characterised in that said software means provide for an internal trigger for the coordinated image recording.
4. Inspection device according to claim 2, characterised in that said software means are provided to be triggered by an external trigger signal to control the coordinated image recording.
5. Inspection device according to claim 1, characterised in that said device comprises optical means and sensor means for digital imaging, display screen means andor memory means.
6. Inspection device according to claim 5, characterised in that said memory means comprise removableexchangeable memory means.
7. Inspection device according to claim 5, characterised in that said sensor means for digital imaging comprise Charged Coupled Device (CCD) sensors.
8. Inspection device according to claim 5, characterised in that said sensor means for digital imaging comprise Complementary Metal Oxide Semiconductor (CMOS) sensors.
9. Inspection device according to claim 1, characterised in that said software means are provided for recording a burst (Rt) of 5 to 250 msec comprising a number of recorded frames (Nrf) between 3 and 200 frames at a frame recording frequency between 100 and 1000 framessec, and for reproducing said recorded burst as a slow motion representation during a time (Cms) ranging from 0.1 to 5 seconds corresponding to the duration of said repetitive event of defined duration, or a multiple thereof, at a reproduction frame frequency (Rff) ranging from 16-60 framessec.
10. Inspection device according to claim 9, characterised in that the device is provided for a number of recorded frames ranging from 5 to 50 frames.
11. Inspection device according to claim 1, characterised in that it comprises lighting means.
12. Inspection method for fast repetitive events of defined duration, involving recording successive images of the repetitive event and providing a synchronised slow motion representation of the recorded successive images of the repetitive event during the total duration of the repetitive event or a multiple thereof, characterised in that said method involves high frame rate image recording of a limited burst of successive images of a fraction of one event, and synchronised slow motion representation of said limited burst of successive images during the total duration of said one event or multiple thereof.
13. Method according to claim 12, characterised in that said high frame rate image recording of said burst of images of a fraction of one event and said synchronised slow motion representation of said burst are controlled by an adjustable triggering signal.
14. Method according to claim 13, characterised in that said adjustable triggering signal is an adjustable internal repetitive triggering signal.
15. Method according to claim 14, characterised in that the starting time for reproducing the recorded images (Str) is calculated from the triggering signal in function of the process cycle time (Cms).
16. Method according to claim 13, characterised in that said adjustable triggering signal is an adjustable external triggering signal.
17. Inspection method according to claim 12, characterised in that it involves a total process cycle time (Cms) ranging from 0.1 to 5 seconds, a slow motion representation of a fraction of the process cycle ranging from 5 to 250 msec, recorded as a time burst (Rt), comprising a number of recorded frames (Nrf) ranging from 5 to 200 frames, at a frame recording frequency (Frf) ranging from 100 to 5000 framessec, whereas the slow motion representation involves a reproduction frame frequency (Rff) ranging from 16-60 framessec.
18. Method according to claim 17, characterised in that the number of recorded frames (Nrf) ranges from 5 to 50 frames.
19. Method according to claim 17, characterised in that the process cycle time (Cms), the recorded burst time (Rt), the number of recorded frames (Nrf), the frame recording frequency (Frf) and the reproduction frame frequency (Rff) are linked by the following formulae
Rt=k\xb7Cms*RffFrf ms,
in which k is a factor expressing the number of process cycles during which the record burst (and optionally a \u201cseparation pause\u201d) is reproduced,
Nrf=Rt*Frf
and
Nrf=k\xb7Cms*Rff
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A compound having the formula:
wherein R1 is H, alkyl, substituted alkyl, halogenated alkyl, cylcoalkyl, cycloheteroalkyl, functionalized alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, halogen, nitro, sulfone, sulfoxide, sulfamide, phosphate, alkylphosphate, boronic acid, or boronic ester, whether monosubstituted or polysubstituted with one of or combinations of R1; X is O, S, N, CH2, or NR2, wherein R2 is alkyl, aryl, heteroaryl, ketone, acyl, ester, COOH; n=0-8, saturated or unsaturated; Y is O, S, N, CH2, NR1, or NR2; m=0-3; R3, R4, R5, and R6 are each independently C or N; and R7 is H, OH, halogen, amine, CH2OH, COOH, OCH3, R1, NHR1, NR1R1, NR1R2, acyl, halogenated acyl, substituted acyl, or heterocylic, whether monosubstituted or polysubstituted with one of or combinations of R7.
2. The compound of claim 1, wherein when R7 is H, alkyl, or substituted alkyl, at least one of X and Y is S, or both X and Y are O.
3. The compound of claim 1, wherein at least one of R3, R4, R5, and R6 is N.
4. The compound of claim 1, wherein R1 is NO2.
5. The compound of claim 1, wherein X is O.
6. The compound of claim 1, wherein X is S.
7. The compound of claim 1, wherein Y is N.
8. The compound of claim 1, wherein Y is S.
9. The compound of claim 1, wherein Y is O.
10. The compound of claim 1, wherein Y is NR1 or NR2.
11. The compound of claim 1, wherein m is 0 or 1.
12. The compound of claim 1, wherein n is 0.
13. The compound of claim 1, wherein each of R3, R4, R5, and R6 are C.
14. The compound of claim 1, wherein R7 is OH or CH2OH.
15. The compound of claim 1, wherein R7 Cl or F.
16. The compound of claim 1, wherein R7 is COOH.
17. The compound of claim 1, wherein R7 is methyl.
18. The compound of claim 1, wherein R7 is CN.
19. The compound of claim 1, wherein R7 OCH3 or OCOCH3.
20. The compound of claim 1, wherein R7 is H.
21. The compound of claim 1, wherein R7 is substituted at one or both of R4 and R6.
22. The compound of claim 1, wherein R7 is substituted at R6.
23. The compound of claim 1, wherein R1 is NO2, R3-R6 are C, R7 is OH substituted at R3, m is 1, n is 0, X is O, and Y is N.
24. The compound of claim 1, wherein the compound is 2-(5-nitrofuran-2-yl)-3H-benzodimidazol-4-ol.
25. A compound having the formula:
wherein R1 is H, alkyl, substituted alkyl, halogenated alkyl, cylcoalkyl, cycloheteroalkyl, functionalized alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, halogen, nitro, sulfone, sulfoxide, sulfamide, phosphate, alkylphosphate, boronic acid, or boronic ester, whether monosubstituted or polysubstituted with one of or combinations of R1; X is O, S, N, CH2, or NR2, wherein R2 is alkyl, aryl, heteroaryl, ketone, acyl, ester, COOH; n=0-8, saturated or unsaturated; Y is O, S, N, CH2, NR1, or NR2; m=0-3; and R3 is CO2CH3, acyl, ester, carbamate, urea, sugar, or amino acid.
26. The compound of claim 25, wherein R3 is COCH3.
27. A compound having the formula:
wherein R1 is H, alkyl, substituted alkyl, halogenated alkyl, cylcoalkyl, cycloheteroalkyl, functionalized alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, halogen, nitro, sulfone, sulfoxide, sulfamide, phosphate, alkylphosphate, boronic acid, or boronic ester, whether monosubstituted or polysubstituted with one of or combinations of R1; X is O, S, N, CH2, or NR2, wherein R2 is alkyl, aryl, heteroaryl, ketone, acyl, ester, COOH; Y is O, S, N, CH2, NR1, or NR2; m=0-3; R3, R4, R5, and R6 are each independently C or N; and R7 is H, OH, halogen, amine, CH2OH, COOH, OCH3, R1, NHR1, NR1R1, NR1R2, acyl, halogenated acyl, substituted acyl, or heterocylic, whether monosubstituted or polysubstituted with one of or combinations of R7.
28. A compound having the formula:
wherein R1 is H, alkyl, substituted alkyl, halogenated alkyl, cylcoalkyl, cycloheteroalkyl, functionalized alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, halogen, nitro, sulfone, sulfoxide, sulfamide, phosphate, alkylphosphate, boronic acid, or boronic ester, whether monosubstituted or polysubstituted with one of or combinations of R1; X is O, S, N, CH2, or NR2, wherein R2 is alkyl, aryl, heteroaryl, ketone, acyl, ester, COOH; n=0-8, saturated or unsaturated; Y is O, S, N, CH2, NR1, or NR2; Z is C or N; m=0-3; R3, R4, and R5, are each independently C or N; and R6 is H, OH, halogen, amine, CH2OH, COOH, OCH3, R1, NHR1, NR1R1, NR1R2, acyl, halogenated acyl, substituted acyl, or heterocylic, whether monosubstituted or polysubstituted with one of or combinations of R6.
29. The compound of claim 28, wherein R1 is NO2, R3-R5 are C, R6 is OH, M and N are 0, X is NCH3, and Y and Z are N.
30. The compound of claim 28, wherein R1 is NO2, R3-R5 are C, R6 is NH2, M and N are 0, X is O, Y is N, and Z is C.
31. A compound having the formula:
wherein R1 and R2 are selected from H and CH2OH, and wherein at least one of R1 and R2 is CH2OH.
32. A method of treating a drug-resistant bacterial strain, comprising:
administering a compound to an individual infected with or suspected of being infected with a methicillin-resistant Staphylococcus aureus strain, a vancomycin-resistant strain, or a linezolid-resistant strain, the compound having the formula:
wherein R1 is H, alkyl, substituted alkyl, halogenated alkyl, cylcoalkyl, cycloheteroalkyl, functionalized alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, halogen, nitro, sulfone, sulfoxide, sulfamide, phosphate, alkylphosphate, boronic acid, or boronic ester, whether monosubstituted or polysubstituted with one of or combinations of R1; X is O, S, N, CH2, or NR2, wherein R2 is alkyl, aryl, heteroaryl, ketone, acyl, ester, COOH; n=0-8, saturated or unsaturated; Y is O, S, N, CH2, NR1, or NR2; m=0-3; R3, R4, R5, and R6 are each independently C or N; and R7 is H, OH, halogen, amine, CH2OH, COOH, OCH3, R1, NHR1, NR1R1, NR1R2, acyl, halogenated acyl, substituted acyl, or heterocylic, whether monosubstituted or polysubstituted with one of or combinations of R7.
33. The method of claim 32, wherein when R7 is H, alkyl, or substituted alkyl, at least one of X and Y is S, or both X and Y are O.
34. The method of claim 32, wherein at least one of R3, R4, R5, and R6 is N.
35. The method of claim 32, wherein R1 is NO2.
36. The method of claim 32, wherein X is O.
37. The method of claim 32, wherein X is S.
38. The method of claim 32, wherein Y is N.
39. The method of claim 32, wherein Y is S.
40. The method of claim 32, wherein Y is O.
41. The method of claim 32, wherein Y is NR1 or NR2.
42. The method of claim 32, wherein m is 0 or 1.
43. The method of claim 32, wherein n is 0.
44. The method of claim 32, wherein each of R3, R4, R5, and R6 are C.
45. The method of claim 32, wherein R7 is OH or CH2OH.
46. The method of claim 32, wherein R7 Cl or F.
47. The method of claim 32, wherein R7 is COOH.
48. The method of claim 32, wherein R7 is methyl.
49. The method of claim 32, wherein R7 is CN.
50. The method of claim 32, wherein R7 OCH3 or OCOCH3.
51. The method of claim 32, wherein R7 is H.
52. The method of claim 32, wherein R7 is substituted at one or both of R4 and R6.
53. The method of claim 32, wherein R7 is substituted at R6.
54. The compound of claim 1, wherein R1 is NO2, R3-R6 are C, R7 is OH substituted at R3, m is 1, n is 0, X is O, and Y is N.
55. The method of claim 32, wherein the compound is 2-(5-nitrofuran-2-yl)-3H-benzodimidazol-4-ol.